I look at Ford's (NYSE: F) and Teladoc's (NYSE: TDOC) earnings in today's video. Here are three reasons these two stocks could be giving long-term investors a buying opportunity with their recent stock price dips. Three reasons Ford could be giving long-term investors a buying opportunity: In a recent interview, the CEO mentioned that Ford's new vehicles, the Mach-E and Bronco, are moving quickly off the lot. Ford is also seeing an increase in the average selling price of the F-Series line. Ford's Q1 earnings were among the strongest results the company has seen, thanks to Ford's continued improvements in its profitability in the U.S. and internationally. One reason for Ford's stock dip is the decrease in vehicle production for the next few quarters due to the chip shortage. The drop in stock price may be a buying opportunity once we get a clear path from the chip shortage. Three reasons Teladoc could be giving long-term investors a buying opportunity: Teladoc's fundamentals are improving. This quarter it saw 430% year-over-year growth in adjusted EBITDA and revenue growth of 151% year over year. Chronic care enrollments are up quarter over quarter and year over year. The growth shows that the Livongo acquisition Teladoc made a few months ago was a great move by management. 2020 accelerated the growth of paid members for Teladoc. Growth seems to be stagnating in 2021, which is one of the reasons the stock price is down. The drop in stock price may be a buying opportunity if guidance shown later this year begins to show growth in members. Click the video below for my full thoughts. *Stock Prices used were the closing prices of April 29, 2021. The video was published on April 29, 2021. 10 stocks we like better than Teladoc HealthWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Teladoc Health wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of February 24, 2021 Jose Najarro owns shares of Teladoc Health. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy. Jose is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.Source